3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as hdac6 inhibitors
RS68111B1Active Publication Date: 2026-06-30ORYZON GENOMICS SA
Patent Information
- Authority / Receiving Office
- RS · RS
- Patent Type
- Patents
- Current Assignee / Owner
- ORYZON GENOMICS SA
- Filing Date
- 2020-06-05
- Publication Date
- 2026-06-30
Need to check novelty before this filing date? Find Prior Art
No text content released.